{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,27]],"date-time":"2026-02-27T20:26:28Z","timestamp":1772223988528,"version":"3.50.1"},"reference-count":40,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2020,1,20]],"date-time":"2020-01-20T00:00:00Z","timestamp":1579478400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2020,1,20]],"date-time":"2020-01-20T00:00:00Z","timestamp":1579478400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Loss-of-function mutations in <jats:italic>IL36RN<\/jats:italic> cause generalized pustular psoriasis (GPP), which is characterized by neutrophil-infiltrated lesions. Neutrophils are important during contact hypersensitivity in mice. However, it has never been determined whether interleukin-36 receptor antagonist (IL-36Ra) deficiency is an exacerbating factor in contact dermatitis. We examined whether a loss-of-function <jats:italic>IL36RN<\/jats:italic> mutation exacerbates contact dermatitis and evaluated the changes in contact dermatitis-related cytokines. Wild-type and <jats:italic>Il36rn<\/jats:italic><jats:sup>\u2212\/\u2212<\/jats:sup> mice were treated with 1-fluoro-2,4-dinitorobenzene (DNFB) and evaluated for ear thickness, histopathological features, numbers of infiltrated neutrophils, and numbers of CD4\u2009+\u2009and CD8\u2009+\u2009T cells. Furthermore, mRNA levels of contact dermatitis-related cytokines were measured by real-time polymerase chain reaction, and effects of TAK-242, a toll-like receptor 4 (TLR4) inhibitor, on the contact hypersensitivity (CHS) response were evaluated. We found that the ear thickness, cytokine expression, and neutrophil infiltration significantly increased in <jats:italic>Il36rn<\/jats:italic><jats:sup>\u2212\/\u2212<\/jats:sup> mice compared with that in wild-type mice. TAK-242 alleviated CHS and prevented neutrophil infiltration, cytokine expression, and ear thickening in <jats:italic>Il36rn<\/jats:italic><jats:sup>\u2212\/\u2212<\/jats:sup> mice. These data indicate that <jats:italic>Il36rn<\/jats:italic><jats:sup>\u2212\/\u2212<\/jats:sup> mutations are an exacerbating factor for CHS and that TAK-242 can reduce the inflammatory responses that are associated with the CHS response.<\/jats:p>","DOI":"10.1038\/s41598-020-57550-5","type":"journal-article","created":{"date-parts":[[2020,1,20]],"date-time":"2020-01-20T11:03:40Z","timestamp":1579518220000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":11,"title":["TAK-242 ameliorates contact dermatitis exacerbated by IL-36 receptor antagonist deficiency"],"prefix":"10.1038","volume":"10","author":[{"given":"Hidehiko","family":"Fukushima","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yohei","family":"Iwata","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Soichiro","family":"Watanabe","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kenta","family":"Saito","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yoshihito","family":"Tanaka","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yurie","family":"Hasegawa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Masashi","family":"Akiyama","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kazumitsu","family":"Sugiura","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2020,1,20]]},"reference":[{"key":"57550_CR1","doi-asserted-by":"publisher","first-page":"1811","DOI":"10.1016\/j.jid.2016.04.038","volume":"136","author":"M Tauber","year":"2016","unstructured":"Tauber, M. et al. IL36RN Mutations Affect Protein Expression and Function: A Basis for Genotype-Phenotype Correlation in Pustular Diseases. J. Invest. Dermatol. 136, 1811\u20131819 (2016).","journal-title":"J. Invest. Dermatol."},{"key":"57550_CR2","doi-asserted-by":"publisher","first-page":"620","DOI":"10.1056\/NEJMoa1013068","volume":"365","author":"S Marrakchi","year":"2011","unstructured":"Marrakchi, S. et al. Interleukin-36-receptor antagonist deficiency and generalized pustular psoriasis. N. Engl. J. Med. 365, 620\u2013628 (2011).","journal-title":"N. Engl. J. Med."},{"key":"57550_CR3","doi-asserted-by":"publisher","first-page":"432","DOI":"10.1016\/j.ajhg.2011.07.022","volume":"89","author":"AS Onoufriadis","year":"2011","unstructured":"Onoufriadis, A. S. et al. Mutations in IL36RN\/IL1F5 are associated with the severe episodic inflammatory skin disease known as generalized pustular psoriasis. Am. J. Hum. Genet. 89, 432\u2013437 (2011).","journal-title":"Am. J. Hum. Genet."},{"key":"57550_CR4","doi-asserted-by":"publisher","first-page":"1440","DOI":"10.4049\/jimmunol.167.3.1440","volume":"167","author":"RT Debets","year":"2001","unstructured":"Debets, R. T. et al. Two novel IL-1 family members, IL-1 delta and IL-1 epsilon, function as an antagonist and agonist of NF-kappa B activation through the orphan IL-1 receptor-related protein 2. J. Immunol. 167, 1440\u20131446 (2001).","journal-title":"J. Immunol."},{"key":"57550_CR5","doi-asserted-by":"publisher","first-page":"2514","DOI":"10.1038\/jid.2013.230","volume":"133","author":"K Sugiura","year":"2013","unstructured":"Sugiura, K. et al. The majority of generalized pustular psoriasis without psoriasis vulgaris is caused by deficiency of interleukin-36 receptor antagonist. J. Invest. Dermatol. 133, 2514\u20132521 (2013).","journal-title":"J. Invest. Dermatol."},{"key":"57550_CR6","doi-asserted-by":"publisher","first-page":"105","DOI":"10.1016\/j.jdermsci.2018.01.012","volume":"90","author":"M Akiyama","year":"2018","unstructured":"Akiyama, M., Takeichi, T., McGrath, J. A. & Sugiura, K. Autoinflammatory keratinization diseases: An emerging concept encompassing various inflammatory keratinization disorders of the skin. J. Dermatol. Sci. 90, 105\u2013111 (2018).","journal-title":"J. Dermatol. Sci."},{"key":"57550_CR7","doi-asserted-by":"publisher","first-page":"1545","DOI":"10.1016\/j.jaci.2017.05.019","volume":"140","author":"M Akiyama","year":"2017","unstructured":"Akiyama, M., Takeichi, T., McGrath, J. A. & Sugiura, K. Autoinflammatory keratinization diseases. J. Allergy Clin. Immunol. 140, 1545\u20131547 (2017).","journal-title":"J. Allergy Clin. Immunol."},{"key":"57550_CR8","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1016\/j.jaut.2017.01.007","volume":"80","author":"A Shibata","year":"2017","unstructured":"Shibata, A. et al. Toll-like receptor 4 antagonist TAK-242 inhibits autoinflammatory symptoms in DITRA. J. Autoimmun. 80, 28\u201338 (2017).","journal-title":"J. Autoimmun."},{"key":"57550_CR9","doi-asserted-by":"publisher","first-page":"13677","DOI":"10.1074\/jbc.M400117200","volume":"279","author":"JE Towne","year":"2004","unstructured":"Towne, J. E., Garka, K. E., Renshaw, B. R., Virca, G. D. & Sims, J. E. Interleukin (IL)-1F6, IL-1F8, and IL-1F9 signal through IL-1Rrp2 and IL-1RAcP to activate the pathway leading to NF-kappaB and MAPKs. J. Biol. Chem. 279, 13677\u201313688 (2004).","journal-title":"J. Biol. Chem."},{"key":"57550_CR10","doi-asserted-by":"publisher","first-page":"973","DOI":"10.1038\/ni1110-973","volume":"11","author":"CA Dinarello","year":"2010","unstructured":"Dinarello, C. A. et al. IL-1 family nomenclature. Nat. Immunol. 11, 973 (2010).","journal-title":"Nat. Immunol."},{"key":"57550_CR11","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1038\/jid.2008.194","volume":"129","author":"LC Zaba","year":"2009","unstructured":"Zaba, L. C. et al. Psoriasis is characterized by accumulation of immunostimulatory and Th1\/Th17 cell-polarizing myeloid dendritic cells. J. Invest. Dermatol. 129, 79\u201388 (2009).","journal-title":"J. Invest. Dermatol."},{"key":"57550_CR12","doi-asserted-by":"publisher","first-page":"679","DOI":"10.1038\/nri2622","volume":"9","author":"FO Nestle","year":"2009","unstructured":"Nestle, F. O., Di Meglio, P., Qin, J. Z. & Nickoloff, B. J. Skin immune sentinels in health and disease. Nat. Rev. Immunol. 9, 679\u2013691 (2009).","journal-title":"Nat. Rev. Immunol."},{"key":"57550_CR13","doi-asserted-by":"publisher","first-page":"2603","DOI":"10.1084\/jem.20070157","volume":"204","author":"H Blumberg","year":"2007","unstructured":"Blumberg, H. et al. Opposing activities of two novel members of the IL-1 ligand family regulate skin inflammation. J. Exp. Med. 204, 2603\u20132614 (2007).","journal-title":"J. Exp. Med."},{"key":"57550_CR14","doi-asserted-by":"publisher","first-page":"187","DOI":"10.1016\/j.jdermsci.2014.02.006","volume":"74","author":"K Sugiura","year":"2014","unstructured":"Sugiura, K. The genetic background of generalized pustular psoriasis: IL36RN mutations and CARD14 gain-of-function variants. J. Dermatol. Sci. 74, 187\u2013192 (2014).","journal-title":"J. Dermatol. Sci."},{"key":"57550_CR15","doi-asserted-by":"publisher","DOI":"10.1038\/srep15319","volume":"5","author":"CS Moniaga","year":"2015","unstructured":"Moniaga, C. S., Watanabe, S., Honda, T., Nielsen, S. & Hara-Chikuma, M. Aquaporin-9-expressing neutrophils are required for the establishment of contact hypersensitivity. Sci. Rep. 5, 15319 (2015).","journal-title":"Sci. Rep."},{"key":"57550_CR16","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1002\/iid3.16","volume":"2","author":"AD Christensen","year":"2014","unstructured":"Christensen, A. D., Skov, S. & Haase, C. The role of neutrophils and G-CSF in DNFB-induced contact hypersensitivity in mice. Immun. Inflamm. Dis. 2, 21\u201334 (2014).","journal-title":"Immun. Inflamm. Dis."},{"key":"57550_CR17","doi-asserted-by":"publisher","first-page":"431","DOI":"10.1016\/S0002-9440(10)63986-7","volume":"158","author":"M Goebeler","year":"2001","unstructured":"Goebeler, M. et al. Differential and sequential expression of multiple chemokines during elicitation of allergic contact hypersensitivity. Am. J. Pathol. 158, 431\u2013440 (2001).","journal-title":"Am. J. Pathol."},{"key":"57550_CR18","doi-asserted-by":"publisher","first-page":"382","DOI":"10.1111\/j.1600-0625.2012.01471.x","volume":"21","author":"SF Martin","year":"2012","unstructured":"Martin, S. F. Contact dermatitis: from pathomechanisms to immunotoxicology. Exp. Dermatol. 21, 382\u2013389 (2012).","journal-title":"Exp. Dermatol."},{"key":"57550_CR19","doi-asserted-by":"publisher","first-page":"973","DOI":"10.1016\/j.immuni.2011.03.028","volume":"34","author":"A Dudeck","year":"2011","unstructured":"Dudeck, A. et al. Mast cells are key promoters of contact allergy that mediate the adjuvant effects of haptens. Immunity. 34, 973\u2013984 (2011).","journal-title":"Immunity."},{"key":"57550_CR20","doi-asserted-by":"publisher","first-page":"2151","DOI":"10.1084\/jem.20070509","volume":"205","author":"SF Martin","year":"2008","unstructured":"Martin, S. F. et al. Toll-like receptor and IL-12 signaling control susceptibility to contact hypersensitivity. J. Exp. Med. 205, 2151\u20132162 (2008).","journal-title":"J. Exp. Med."},{"key":"57550_CR21","doi-asserted-by":"crossref","unstructured":"Martin, S. F. Rustemeyer, T. & Thyssen, J. P. Recent advances in understanding and managing contact dermatitis. F1000Res, 7 (2018).","DOI":"10.12688\/f1000research.13499.1"},{"key":"57550_CR22","doi-asserted-by":"publisher","first-page":"e0169397","DOI":"10.1371\/journal.pone.0169397","volume":"12","author":"X Jiang","year":"2017","unstructured":"Jiang, X. et al. Dermal gammadelta T cells do not freely re-circulate out of skin and produce IL-17 to promote neutrophil infiltration during primary contact Hypersensitivity. PLoS One. 12, e0169397 (2017).","journal-title":"PLoS One."},{"key":"57550_CR23","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1084\/jem.20130062","volume":"212","author":"FC Weber","year":"2015","unstructured":"Weber, F. C. et al. Neutrophils are required for both the sensitization and elicitation phase of contact hypersensitivity. J. Exp. Med. 212, 15\u201322 (2015).","journal-title":"J. Exp. Med."},{"key":"57550_CR24","doi-asserted-by":"publisher","first-page":"1685","DOI":"10.1097\/CCM.0b013e3181e7c5c9","volume":"38","author":"TW Rice","year":"2010","unstructured":"Rice, T. W. et al. A randomized, double-blind, placebo-controlled trial of TAK-242 for the treatment of severe sepsis. Crit Care Med. 38, 1685\u20131694 (2010).","journal-title":"Crit Care Med."},{"key":"57550_CR25","doi-asserted-by":"publisher","first-page":"429","DOI":"10.1016\/j.bbrc.2018.10.104","volume":"30","author":"T Numata","year":"2018","unstructured":"Numata, T. et al. IL-36\u03b1 is involved in hapten-specific T-cell induction, but not local inflammation, during contact hypersensitivity. Biochem Biophys Res Commun. 30, 429\u2013436 (2018).","journal-title":"Biochem Biophys Res Commun."},{"key":"57550_CR26","doi-asserted-by":"publisher","first-page":"44","DOI":"10.1016\/j.jdermsci.2012.10.004","volume":"69","author":"JH Peters","year":"2013","unstructured":"Peters, J. H. et al. Co-culture of healthy human keratinocytes and T-cells promotes keratinocyte chemokine production and RORgammat-positive IL-17 producing T-cell populations. J. Dermatol. Sci. 69, 44\u201353 (2013).","journal-title":"J. Dermatol. Sci."},{"key":"57550_CR27","doi-asserted-by":"publisher","first-page":"145","DOI":"10.1016\/j.jaci.2012.04.024","volume":"130","author":"JG Krueger","year":"2012","unstructured":"Krueger, J. G. et al. IL-17A is essential for cell activation and inflammatory gene circuits in subjects with psoriasis. J. Allergy Clin. Immunol. 130, 145\u2013154 e149 (2012).","journal-title":"J. Allergy Clin. Immunol."},{"key":"57550_CR28","doi-asserted-by":"publisher","first-page":"490","DOI":"10.4049\/jimmunol.1100123","volume":"187","author":"AM Lin","year":"2011","unstructured":"Lin, A. M. et al. Mast cells and neutrophils release IL-17 through extracellular trap formation in psoriasis. J. Immunol. 187, 490\u2013500 (2011).","journal-title":"J. Immunol."},{"key":"57550_CR29","first-page":"1092","volume":"159","author":"KE Nograles","year":"2008","unstructured":"Nograles, K. E. et al. Th17 cytokines interleukin (IL)-17 and IL-22 modulate distinct inflammatory and keratinocyte-response pathways. Br. J. Dermatol. 159, 1092\u20131102 (2008).","journal-title":"Br. J. Dermatol."},{"key":"57550_CR30","doi-asserted-by":"publisher","first-page":"646","DOI":"10.1111\/imcb.12029","volume":"96","author":"GM Scholz","year":"2018","unstructured":"Scholz, G. M., Heath, J. E., Walsh, K. A. & Reynolds, E. C. MEK-ERK signaling diametrically controls the stimulation of IL-23p19 and EBI3 expression in epithelial cells by IL-36\u03b3. Immunol. Cell. Biol. 96, 646\u2013655 (2018).","journal-title":"Immunol. Cell. Biol."},{"key":"57550_CR31","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1111\/j.1600-0463.2011.02832.x","volume":"120","author":"AD Christensen","year":"2012","unstructured":"Christensen, A. D. et al. Immunological mechanisms of contact hypersensitivity in mice. APMIS. 120, 1\u201327 (2012).","journal-title":"APMIS."},{"key":"57550_CR32","doi-asserted-by":"publisher","first-page":"347","DOI":"10.1093\/intimm\/dxq030","volume":"22","author":"T Kishimoto","year":"2010","unstructured":"Kishimoto, T. IL-6: from its discovery to clinical applications. Int. Immunol. 22, 347\u2013352 (2010).","journal-title":"Int. Immunol."},{"key":"57550_CR33","doi-asserted-by":"publisher","first-page":"303","DOI":"10.1038\/jid.2012.284","volume":"133","author":"T Honda","year":"2013","unstructured":"Honda, T., Egawa, G., Grabbe, S. & Kabashima, K. Update of immune events in the murine contact hypersensitivity model: toward the understanding of allergic contact dermatitis. J. Invest. Dermatol. 133, 303\u2013315 (2013).","journal-title":"J. Invest. Dermatol."},{"key":"57550_CR34","doi-asserted-by":"publisher","first-page":"242","DOI":"10.1590\/abd1806-4841.20186340","volume":"93","author":"MC Silvestre","year":"2018","unstructured":"Silvestre, M. C., Sato, M. N. & Reis, V. Innate immunity and effector and regulatory mechanisms involved in allergic contact dermatitis. An. Bras. Dermatol. 93, 242\u2013250 (2018).","journal-title":"An. Bras. Dermatol."},{"key":"57550_CR35","doi-asserted-by":"publisher","first-page":"163","DOI":"10.1016\/j.jaci.2017.02.022","volume":"141","author":"F Hacini-Rachinel","year":"2018","unstructured":"Hacini-Rachinel, F. et al. Intestinal dendritic cell licensing through Toll-like receptor 4 is required for oral tolerance in allergic contact dermatitis. J. Allergy Clin. Immunol. 141, 163\u2013170 (2018).","journal-title":"J. Allergy Clin. Immunol."},{"key":"57550_CR36","doi-asserted-by":"publisher","first-page":"364","DOI":"10.1111\/exd.12383","volume":"23","author":"R Panzer","year":"2014","unstructured":"Panzer, R., Blobel, C., F\u00f6lster-Holst, R. & Proksch, E. TLR2 and TLR4 expression in atopic dermatitis, contact dermatitis and psoriasis. Exp. Dermatol. 23, 364\u2013366 (2014).","journal-title":"Exp. Dermatol."},{"key":"57550_CR37","doi-asserted-by":"publisher","first-page":"39","DOI":"10.5414\/ALX01274E","volume":"1","author":"SF Martin","year":"2017","unstructured":"Martin, S. F. The role of the innate immune system in allergic contact dermatitis. Allergol. Select. 1, 39\u201343 (2017).","journal-title":"Allergol. Select."},{"key":"57550_CR38","doi-asserted-by":"publisher","first-page":"353","DOI":"10.1146\/annurev.immunol.24.021605.090552","volume":"24","author":"B Beutler","year":"2006","unstructured":"Beutler, B. et al. Genetic analysis of host resistance: Toll-like receptor signaling and immunity at large. Annu. Rev. Immunol. 24, 353\u2013389 (2006).","journal-title":"Annu. Rev. Immunol."},{"key":"57550_CR39","doi-asserted-by":"publisher","first-page":"813","DOI":"10.1111\/exd.12272","volume":"22","author":"M Mattii","year":"2013","unstructured":"Mattii, M. et al. The balance between pro- and anti-inflammatory cytokines is crucial in human allergic contact dermatitis pathogensis: the role of IL-1 family members. Exp Dermatol. 22, 813\u2013819 (2013).","journal-title":"Exp Dermatol."},{"key":"57550_CR40","doi-asserted-by":"publisher","first-page":"1761","DOI":"10.4049\/jimmunol.1100928","volume":"188","author":"DD Kish","year":"2012","unstructured":"Kish, D. D., Gorbachev, A. V. & Fairchild, R. L. IL-1 receptor signaling is required at multiple stages of sensitization and elicitation of the contact hypersensitivity response. J. Immunol. 188, 1761\u20131771 (2012).","journal-title":"J. Immunol."}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-020-57550-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-020-57550-5","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-020-57550-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,12,6]],"date-time":"2022-12-06T05:56:46Z","timestamp":1670306206000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-020-57550-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,1,20]]},"references-count":40,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2020,12]]}},"alternative-id":["57550"],"URL":"https:\/\/doi.org\/10.1038\/s41598-020-57550-5","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,1,20]]},"assertion":[{"value":"2 August 2019","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 January 2020","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 January 2020","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"734"}}